000			04034nam a22003377a 4500
003			OSt
005			20240305192437.0
008			220530b |||||||| |||| 00| 0 eng d
020			_a159259154X
020			_a9781592591541
040			_cdlc
050			_aRC685.C18 C37 2002
050			_a WG 300 C26749 2002
082			_a 616.1'2–dc21
100			_a David Hasdai _938209
245			_aCardiogenic Shock _b Contemporary Cardiology
250			_a illustrated
260			_a999 Riverview Drive, Suite 208 Totowa, New Jersey 07512 _b Springer Science & Business Media _c2002
300			_a 381 pages
505			_aContents: CONTENTS PART I INTRODUCTION 1 INTRODUCTION CARDIOGENIC SHOCK COMPLICATING ACUTE Contemporary Cardiology Cardiogenic Shock Diagnosis and Treatment Cardiogenic Shock Complicating STSegment Elevation CONTEMPORARY TREATMENT OF THE PATIENT WITH Technical Approaches to Percutaneous Revascularization Operative Management of Nonischemic Cardiogenic Shock CARDIAC CONDITIONS 213 Myocarditis and Cardiogenic Shock Pericardial Disease and Cardiogenic Shock Heart Disease in the Child and Cardiogenic Shock Congenital Heart Disease in the Adult Transport of the Patient with Cardiogenic Shock Percutaneous Mechanical Assist Devices for Severe Mechanical Alternatives to the Human Heart MECHANICAL COMPLICATIONS OF ACUTE MYOCARDIAL Percutaneous Treatment of Acute Mechanical Complications HEART DISEASE 151 Cardiogenic Shock Related to Valvular Heart Disease Percutaneous Valvuloplasty in Cardiogenic Shock Future Perspective 357 Jonathan Leor Israel M Barbash Alexander Battler Index
520			_aLeading world authorities drawn from cardiology, surgery, pediatrics, internal medicine, and basic science comprehensively survey the diagnostic, therapeutic, and prognostic aspects of cardiogenic shock. These experts describe the different scenarios leading to cardiogenic shock, the ways to diagnose their causes, the unique therapeutic options based on those causes, and the outcomes associated with treatment and without. The book also surveys the biochemical and physiological changes that occur in the heart and other organs during cardiogenic shock, the identification of patients at risk for developing shock, and the novel pharmacological agents and assist devices that can help to stabilize the shock patient. _bCommon terms and phrases: acute myocardial infarction angioplasty Ann Thorac Surg aortic stenosis aortic valve blood flow blood pressure bypass cardiac output cardiac rupture cardiac tamponade cardiogenic shock cardiogenic shock complicating cardiomyopathy catheter catheterization cells Circulation clinical closure complicating acute myocardial coronary artery decrease diagnosis diastolic dobutamine dysfunction echocardiography free wall rupture function Hasdai heart disease heart failure hemodynamic IABP implanted increase injury inotropic intervention intra-aortic balloon pump ischemia ischemic JAm Coll Cardiol left ventricle left ventricular assist LVAD mechanical mitral regurgitation mitral valve mortality myocardium outcome oxygen papillary muscle papillary muscle rupture patients with acute patients with cardiogenic percutaneous postinfarction prosthetic valve pulmonary artery Registry repair reperfusion reported revascularization right ventricular risk shock complicating acute surgical survival syndrome systemic systolic Thorac Cardiovasc Surg thrombolytic therapy tion tissue transplantation trauma treatment valve replacement valvular valvuloplasty vascular venous ventricular assist device ventricular free wall ventricular septal rupture VFWR
600			_xMedical / Clinical Medicine _926816
600			_x Medical / Cardiology _926817
600			_x Medical › Cardiology _927540
600			_xShock, Cardiogenic. _938210
600			_x Heart Diseases–complications. _938211
700			_aPeter B. Berger _938212
700			_a Alexander Battler _938213
700			_a David R. Holmes Jr. _938214
942			_2ddc _cEB
999			_c6749 _d6749